Similar articles

• Hepatitis C in kidney transplant patients.

  Oka T, Yasumura T. Oka T, et al. Transplant Proc. 1996 Jun;28(3):1163-7. Transplant Proc. 1996. PMID: 8658612 No abstract available.
• Effect of chronic liver disease on clinical outcome in renal allograft recipients.

  Durlik M, Gaciong Z, Soluch L, Rowińska D, Rancewicz Z, Kozłowska-Boszko B, Lewandowski Z, Rowiński W, Szmidt J, Lao M. Durlik M, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):787-90. doi: 10.1016/s0041-1345(96)00102-9. Transplant Proc. 1997. PMID: 9123526 No abstract available.
• Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.

  Durlik M, Gaciong Z, Soluch L, Rowińska D, Kozłowska-Boszko B, Rowiński W, Szmidt J, Lao M. Durlik M, et al. Transplant Proc. 1996 Dec;28(6):3459-60. Transplant Proc. 1996. PMID: 8962347 No abstract available.
• Renal transplantation in patients positive for hepatitis B or C (pro).

  Morales JM. Morales JM. Transplant Proc. 1998 Aug;30(5):2064-9. doi: 10.1016/s0041-1345(98)00542-9. Transplant Proc. 1998. PMID: 9723394 Review. No abstract available.
• Hepatitis and solid organ transplantation.

  Pol S, Samuel D, Cadranel J, Legendre C, Bismuth H, Bréchot C, Kreis H. Pol S, et al. Transplant Proc. 2000 Mar;32(2):454-7. doi: 10.1016/s0041-1345(00)00816-2. Transplant Proc. 2000. PMID: 10715478 Review. No abstract available.